COMP <GO>
PNR vs TMO // OPERATING MARGIN
Pentair plc. Ordinary Share (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PNR 9
— TMO 5
▲ OPERATING MARGIN LEADER: PNR
LAST: $66.26 (+0.64%) • MKT CAP: $10.51B
operating-margins
20.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PNR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PNR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.50% | 41.00% | -0.50 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.50% | 9.30% | +3.20 | PNR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 30.4x | -17.20 | PNR | /valuation <GO> |
| Free Cash Flow Yield | 7.10% | 2.40% | +4.70 | PNR | /fcf-yield <GO> |
| Operating Margin ACTIVE | 20.50% | 17.40% | +3.10 | PNR | /operating-margins <GO> |
| Net Profit Margin | 15.70% | 15.10% | +0.60 | PNR | /net-margins <GO> |
| Revenue Growth (YoY) | 2.30% | 3.90% | -1.60 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.56% | 0.24% | +1.32 | PNR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.80 | 4.50 | -0.70 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 82.5 | 59.1 | +23.36 | PNR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.94 | +0.10 | PNR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.0x | 36.3x | -21.30 | PNR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.51B | $262.22B | -$251.71B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PNR REV | TMO REV | PNR GROSS % | TMO GROSS % | PNR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.18B | $44.56B | 40.5% | 44.0% | $746.0M | $6.29B |
| FY 2024 | $4.08B | $42.88B | 39.2% | 44.0% | $692.3M | $7.27B |
| FY 2023 | $4.10B | $42.86B | 44.0% | 44.0% | $434.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PNR // BETA 1.04
TMO // BETA 0.94